Wound Innovations Investment Opportunity
Invest in Australia's only wound care specialist – a huge opportunity to be part of a first-mover with Government-funded IP that’s commercially proven and set to address the over $3 billion cost per year to the healthcare system.
Wound Innovations Investment Opportunity
Wound Innovations is Australia’s only Wound Care Specialist with Government-funded Intellectual Property from a $7.9 million research project. With the IP developed from the Wound Management Innovation Cooperative Research Centre (WMI CRC), Wound Innovations has spun out to become a commercially proven company and is now set for immediate expansion to address an annual $221 million wound care market.
Wound Innovations has shown how innovative treatment can significantly reduce wound healing time, generating a growing list of patients nationwide.
Investment Highlights
- Australia’s only wound care specialist developed with 7.9 million of Government-funded Intellectual property which is commercially proven
- Initial focus is targeting an unmet $221 million wound care market with potential to address a further $3 billion burden in the Australian healthcare system
- Wound Innovations has seen a first-mover advantage with consistent growth at an average of 9% month-on-month for the last 2 years
- Total gross margin is forecast to grow from approximately 45% in 2020 to 53% by 2022
- Wound Innovations forecasts revenue to grow fourfold to $4.3 million in 2022
Request Offer Docs
By clicking submit, I agree to the terms of the Reach Markets Financial Services Guide that includes the Privacy Statement. Reach Markets are the advisors assisting with the management of this offer and may receive fees depending on whether an offer is taken up by investors.